February 2008

UP FRONT
Editor's Page: No Clear Choice in Osteoporosis Treatments
By Michael Kleerekoper, MD, MACE

ETIOLOGY OF DIABETES
Role of Inflammatory Cytokines in Type 2 Diabetes
By Cathy C. Lee, MD, MS; and Simin Liu, MD, ScD

HYPERLIPIDEMIA AND HYPERTENSION
HDL Cholesterol: Rationale for Targeting Lipid Levels Beyond LDL Cholesterol
By Atil Y. Kargi, MD; and Dace L. Trence, MD, FACE

COVER STORY
Strontium Ranelate in the Management of Spinal and Peripheral Osteoporosis
By Jean-Yves Reginster, MD, PhD; Julien Collette, PhD; Audrey Neuprez, MSc; and Olivier Bruyere, PhD

High-Frequency Vibrations for the Prevention and Treatment of Osteoporosis
Reviewed by Douglas P. Kiel, MD, MPH; and Clinton T. Rubin, PhD

Management of Normocalcemic Primary HPT
By Adeel Ghaffar, BSc, MRCP; J.H. Duncan Bassett, MA, PhD, FRCP; and Graham R. Williams, BSc, PhD, FRCP

Use of Cinacalcet to Control Hyperparathyroidism
By Andreas L. Serra, MD; and Rudolf P Wüthrich, MD

Quality of Life in Primary Hyperparathyroidism
By Joel T. Adler, BA; Rebecca Sippel, MD; and Herbert Chen, MD, FACS

DEPARTMENTS
Clinical Trials in Osteoporosis

Conference Calendar

Industry News and Innovations

5 Questions: Aaron Vinik, MD, PhD, FCP, MACP